B Staels, JC Fruchart - Diabetes, 2005 - Am Diabetes Assoc Peroxisome proliferator–activated receptors (PPARs) play key roles in the
regulation of energy homeostasis and inflammation, and agonists of PPARα and
-γ are currently used therapeutically. Fibrates, first used in the 1970s ... Cited by 269 - Related articles - BL Direct - All 10 versions
RM Krauss - Diabetes Care, 2004 - Am Diabetes Assoc Insulin resistance and type 2 diabetes are associated with a clustering of
interrelated plasma lipid and lipoprotein abnormalities, which include reduced
HDL cholesterol, a predominance of small dense LDL particles, and elevated ... Cited by 183 - Related articles - BL Direct - All 6 versions
- ►ahajournals.org PO Szapary, LAT Bloedon, FF Samaha, D Duffy, … - Arteriosclerosis, thrombosis, and vascular biology, 2006 - Am Heart Assoc Methods and Results— Sixty nondiabetic adults with low HDL-C and MetSyn were
randomized to PIO or matching placebo for 12 weeks. PIO increased HDL-C by 15%
and 14% at 6 and 12 weeks, respectively, compared with placebo (P<0.001). ... Cited by 106 - Related articles - All 10 versions
F Blaschke, Y Takata, E Caglayan, RE Law, … - Arteriosclerosis, thrombosis, and vascular biology, 2006 - Am Heart Assoc Peroxisome proliferator-activated receptors (PPARs) are ligand-activated
transcription factors belonging to the nuclear hormone receptor superfamily. The
3 PPAR isotypes, PPAR- , PPAR- , and PPAR- , play a key role in the ... Cited by 74 - Related articles - All 10 versions
JB Buse, MH Tan, MJ Prince, PP Erickson - Diabetes Obesity and Metabolism, 2004 - interscience.wiley.com Methods: medline was searched for entries indexed from January 1966 to November
2002; search terms included the names of OAMs and serum lipids, limited to
English language and human subjects. We selected clinical studies in type 2 ... Cited by 69 - Related articles - BL Direct - All 4 versions
HA Pershadsingh - eid, 2004 - informahealthcare.com The discovery that the insulin-sensitising thiazolidinediones (TZDs), specific
peroxisome proliferator-activated receptor-γ (PPARγ) agonists, have antipro-
liferative, anti-inflammatory and immunomodulatory effects has led to the ... Cited by 69 - Related articles - All 5 versions
CJ Bailey - Diabetes Obesity and Metabolism, 2005 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 50 - Related articles - BL Direct - All 5 versions
- ►cardiovascres.org D Li, K Chen, N Sinha, X Zhang, Y Wang, AK … - Cardiovascular research, 2005 - cardiovascres.org Methods and results: Sprague–Dawley rats were fed chow mixed with pioglitazone
(1 or 10 mg/kg/day) for 7 to 10 days. A filter soaked in 30% FeCl 3 was applied
around the abdominal aorta to study the patterns of arterial ... Cited by 45 - Related articles - All 6 versions
- ►endojournals.org K Winkler, C Abletshauser, I Friedrich, MM … - Journal of Clinical Endocrinology & Metabolism, 2004 - Endocrine Soc Increasing PAF-AH activity was significantly associated with a positive history
of CAD (+0.7% per IU/liter PAH-AH; P = 0.010), the odds ratio estimate adjusted
for age, gender, and body mass index of the highest quartile being 10.6 (P ... Cited by 42 - Related articles - BL Direct - All 5 versions
- ►ahajournals.org F Meisner, D Walcher, F Gizard, X Kapfer, R … - Arteriosclerosis, thrombosis, and vascular biology, 2006 - Am Heart Assoc Methods and Results— A total of 24 nondiabetic patients with symptomatic
carotid artery stenosis were randomly assigned to rosiglitazone (4 mg BID) or
placebo in addition to standard therapy. In this population of nondiabetic ... Cited by 41 - Related articles - BL Direct - All 9 versions
